| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |